TRANSDERM-NITRO
LOE ApproachingNDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Oct 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRANSDERM-NITRO is a transdermal extended-release nitrate film approved in 1981 for chronic angina and heart failure management. It delivers nitrates through the skin as a small-molecule vasodilator to reduce cardiac workload and improve coronary blood flow. The product represents a landmark innovation in transdermal drug delivery technology.
LOE Approaching
As LOE approaches, commercial teams are likely focused on lifecycle extension strategies, patient retention, and defending market share against generic and alternative therapies; team size may be optimized or consolidating.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TRANSDERM-NITRO offers stability in managing a mature, legacy brand with deep market penetration and loyal patient base, but limited growth upside. Career advancement typically involves transitioning to higher-growth products or taking on strategic lifecycle management roles that prepare candidates for LOE defense and portfolio optimization.
Brand ManagerMedical Science Liaison
Worked on TRANSDERM-NITRO at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.